Acromegaly : comorbidities and novel diagnostic tools
Background/aim: Acromegaly is a rare disease caused by a pituitary tumor secreting excess growth hormone, which leads to acral growth, organ enlargement, and facial changes.
Vouzouneraki, Konstantina
core +2 more sources
Pasireotide: a novel treatment for patients with acromegaly
, 2016 Daniel Cuevas-Ramos,1 Maria Fleseriu2,3 1Department of Endocrinology and Metabolism, Neuroendocrinology Clinic, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; 2Department of Medicine ...
Cuevas-Ramos D, Fleseriu M
core
Tumor expression of dopamine receptor and prolactin is associated with acute dopamine agonist response in acromegaly. [PDF]
Front Endocrinol (Lausanne)Atai S +7 more
europepmc +1 more source
Acromegaly as the Initial Presentation of Multiple Endocrine Neoplasia Type 1: A Case Report. [PDF]
Am J Case RepOdeh HYH +3 more
europepmc +1 more source
Scleroderma-Like Phenotype in a Patient With Transthyretin Cardiac Amyloidosis and Acromegaly: A Triple Diagnostic Challenge. [PDF]
CureusJaved A, Debuys P, Nguyen K.
europepmc +1 more source
Familial acromegaly with a novel <i>PRKAR1A</i> splice-acceptor variant and marked intrafamilial phenotypic variability. [PDF]
JCEM Case RepJha V +5 more
europepmc +1 more source
Acromegaly and Metabolic Dysfunction-Associated Steatotic Liver Disease: Clinical and Therapeutic Implications. [PDF]
Curr Obes RepPolyzos SA, Mantovani A, Targher G.
europepmc +1 more source
Malignancy in patients with acromegaly: a multicenter study across the Gulf region. [PDF]
Ann Saudi MedAlDahmani K +7 more
europepmc +1 more source